Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 7
Research Paper
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
Joon Hyung Kima GSK, Rockville, MD, USACorrespondence[email protected]
https://orcid.org/0000-0002-6014-3543View further author information
https://orcid.org/0000-0002-6014-3543View further author information, John Diaz-Decaroa GSK, Rockville, MD, USAhttps://orcid.org/0000-0001-6487-2113View further author information
https://orcid.org/0000-0001-6487-2113View further author information, , Shinn-Jang Hwangc Department of Family Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan;d National Yang Ming University School of Medicine, Taipei City, Taiwanhttps://orcid.org/0000-0003-3217-6193View further author information
https://orcid.org/0000-0003-3217-6193View further author information, , , , , , , , , , , , , Yanfei Yuanb GSK, Beijing, Chinahttps://orcid.org/0000-0002-5366-2599View further author information
https://orcid.org/0000-0002-5366-2599View further author information, Toufik Zahaff GSK, Wavre, Belgiumhttps://orcid.org/0000-0002-2049-5210View further author information
https://orcid.org/0000-0002-2049-5210View further author information, Anthony L. Cunninghamp The Westmead Institute for Medical Research, Westmead, Australia;q University of Sydney, Sydney, Australiahttps://orcid.org/0000-0002-6744-5667View further author information
https://orcid.org/0000-0002-6744-5667View further author information & Anne Schuinda GSK, Rockville, MD, USAhttps://orcid.org/0000-0003-3544-0682View further author information
https://orcid.org/0000-0003-3544-0682View further author information show all